The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Goeltz Ii Robert C. since 2016.
This trader's CIK number is 1653881.
At the time of last reporting, Goeltz Ii Robert C. was the Chief Financial Officer of Arcus Biosciences, Inc.. (stock ticker symbol RCUS).
Also see all insider trading activities at Arcus Biosciences, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | CTMX | 0 | $0 | 21,517 | $426,036 | 46,984 | $231,543 |
| 2016 | CTMX | 0 | $0 | 0 | $0 | 6,000 | $26,838 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | RCUS | 0 | $0 | 2,004 | $40,080 | 0 | $0 |
| 2023 | RCUS | 0 | $0 | 4,049 | $81,141 | 0 | $0 |
| 2021 | RCUS | 0 | $0 | 1,106 | $44,321 | 0 | $0 |
| 2020 | RCUS | 5,000 | $107,850 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | UBX | 0 | $0 | 0 | $0 | 10,000 | $34,300 |
| 2018 | UBX | 0 | $0 | 0 | $0 | 5,000 | $17,150 |
1. Cytomx Therapeutics, Inc. (CTMX)
2. Arcus Biosciences, Inc. (RCUS)
3. Unity Biotechnology, Inc. (UBX)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-05-12 | CTMX | Option Ex | 19,967 | 5.54 | 110,697 |
| 2017-04-10 | CTMX | Option Ex | 3,000 | 4.47 | 13,419 |
| 2017-03-20 | CTMX | Option Ex | 21,517 | 4.47 | 96,245 |
| 2017-03-20 | CTMX | Sale | 21,517 | 19.80 | 426,036 |
| 2017-03-09 | CTMX | Option Ex | 2,500 | 4.47 | 11,182 |
| 2016-09-29 | CTMX | Option Ex | 4,000 | 4.47 | 17,892 |
| 2016-05-12 | CTMX | Option Ex | 2,000 | 4.47 | 8,946 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-01-02 | RCUS | Sale | 2,004 | 20.00 | 40,080 |
| 2023-06-07 | RCUS | Sale | 4,049 | 20.04 | 81,141 |
| 2021-12-16 | RCUS | Sale | 485 | 40.02 | 19,411 |
| 2021-12-17 | RCUS | Sale | 621 | 40.11 | 24,910 |
| 2020-09-09 | RCUS | Buy | 5,000 | 21.57 | 107,850 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-02-24 | UBX | Option Ex | 10,000 | 3.43 | 34,300 |
| 2018-10-10 | UBX | Option Ex | 5,000 | 3.43 | 17,150 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Goeltz Ii Robert C. (Chief Financial Officer of Arcus Biosciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.